Tags: 23andMe
Regeneron Acquires 23andMe for $256M: A Game-Changer in Pharma Data and Customer Insights
Regeneron plans to acquire genetic testing company 23andMe for $256 million following its bankruptcy filing. This acquisition allows Regeneron to utilize 23andMe’s extensive genomic database,…
Congress Investigates 23andMe Bankruptcy: Key Questions and Implications for Genetic Testing Industry
The bankruptcy filing of 23andMe has prompted an investigation by the House Committee on Energy and Commerce regarding the potential risks to customer data. Representatives…
23andMe Declares Bankruptcy: A Step-by-Step Guide to Deleting Your Personal Data
On March 16, 2023, DNA testing service 23andMe filed for bankruptcy protection, raising concerns about the privacy of genetic data belonging to its 15 million…
23andMe’s Uncertain Future: What It Means for Your Genetic Data Privacy
23andMe, a prominent DNA testing company, is facing severe challenges due to a data breach affecting nearly 7 million users and impending bankruptcy. Once valued…
23andMe Files for Bankruptcy Protection: CEO Resigns Amid Financial Turmoil
23andMe, a leading genetics testing firm, has filed for Chapter 11 bankruptcy to facilitate asset sales amid financial struggles. Co-founder and CEO Anne Wojcicki announced…
Recent Post
Cetegories
Join Our Newsletter
Daily Free Our Fashion News
Straight To Your Inbox
Straight To Your Inbox
